Venkat Lakshmi Kishan Vuddanda, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Appendage | 8 | 2019 | 283 | 1.360 |
Why?
|
| Octreotide | 1 | 2017 | 145 | 0.580 |
Why?
|
| Atrial Fibrillation | 7 | 2019 | 5034 | 0.560 |
Why?
|
| Insurance Claim Review | 1 | 2019 | 720 | 0.500 |
Why?
|
| Arteriovenous Malformations | 1 | 2017 | 396 | 0.480 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2019 | 3537 | 0.380 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2017 | 1130 | 0.360 |
Why?
|
| Catheter Ablation | 5 | 2018 | 2758 | 0.300 |
Why?
|
| Patient Readmission | 1 | 2019 | 3114 | 0.260 |
Why?
|
| Tachycardia, Ventricular | 3 | 2018 | 1273 | 0.260 |
Why?
|
| Stroke | 5 | 2019 | 9981 | 0.250 |
Why?
|
| Defibrillators, Implantable | 2 | 2018 | 1440 | 0.160 |
Why?
|
| Alloys | 1 | 2018 | 122 | 0.150 |
Why?
|
| Injections, Subcutaneous | 1 | 2017 | 666 | 0.140 |
Why?
|
| Atrioventricular Block | 1 | 2017 | 120 | 0.140 |
Why?
|
| Septal Occluder Device | 1 | 2017 | 128 | 0.130 |
Why?
|
| Heart Atria | 2 | 2019 | 1357 | 0.130 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2017 | 478 | 0.120 |
Why?
|
| Postoperative Complications | 4 | 2019 | 15295 | 0.110 |
Why?
|
| Gastrointestinal Agents | 1 | 2017 | 494 | 0.110 |
Why?
|
| Colectomy | 1 | 2017 | 683 | 0.110 |
Why?
|
| Esophagus | 1 | 2018 | 1019 | 0.100 |
Why?
|
| Myocarditis | 1 | 2019 | 771 | 0.100 |
Why?
|
| Monitoring, Intraoperative | 1 | 2018 | 957 | 0.100 |
Why?
|
| Heart-Assist Devices | 2 | 2018 | 1194 | 0.100 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 39050 | 0.100 |
Why?
|
| Hospital Mortality | 3 | 2019 | 5317 | 0.100 |
Why?
|
| Survival Rate | 3 | 2019 | 12788 | 0.090 |
Why?
|
| Primary Prevention | 1 | 2018 | 1167 | 0.090 |
Why?
|
| Coronary Angiography | 2 | 2019 | 4577 | 0.090 |
Why?
|
| Exercise Test | 1 | 2017 | 2074 | 0.090 |
Why?
|
| Heart Diseases | 2 | 2018 | 2788 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2019 | 2616 | 0.080 |
Why?
|
| Heart Transplantation | 2 | 2018 | 3110 | 0.080 |
Why?
|
| Treatment Outcome | 9 | 2019 | 63114 | 0.080 |
Why?
|
| Atrial Function, Left | 2 | 2019 | 173 | 0.080 |
Why?
|
| Electrocardiography | 2 | 2018 | 6442 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2017 | 4199 | 0.070 |
Why?
|
| Inpatients | 1 | 2018 | 2518 | 0.070 |
Why?
|
| Biopsy | 1 | 2018 | 6756 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 1912 | 0.070 |
Why?
|
| Aged | 10 | 2019 | 163280 | 0.070 |
Why?
|
| Registries | 2 | 2018 | 8089 | 0.070 |
Why?
|
| Myocardium | 1 | 2018 | 4776 | 0.070 |
Why?
|
| Acute Coronary Syndrome | 1 | 2018 | 2337 | 0.060 |
Why?
|
| Incidence | 2 | 2019 | 20947 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 2019 | 77449 | 0.060 |
Why?
|
| Male | 13 | 2019 | 350118 | 0.050 |
Why?
|
| United States | 6 | 2019 | 69872 | 0.050 |
Why?
|
| Risk Assessment | 3 | 2018 | 23338 | 0.050 |
Why?
|
| Female | 12 | 2019 | 380194 | 0.050 |
Why?
|
| Echocardiography | 3 | 2019 | 5102 | 0.050 |
Why?
|
| Exercise | 1 | 2017 | 5615 | 0.050 |
Why?
|
| Action Potentials | 2 | 2017 | 1806 | 0.040 |
Why?
|
| Hospitalization | 1 | 2019 | 10262 | 0.040 |
Why?
|
| Humans | 17 | 2019 | 744343 | 0.040 |
Why?
|
| Databases, Factual | 3 | 2019 | 7729 | 0.040 |
Why?
|
| Middle Aged | 8 | 2019 | 213383 | 0.040 |
Why?
|
| Hypertension | 1 | 2018 | 8480 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 6487 | 0.040 |
Why?
|
| Systole | 1 | 2018 | 958 | 0.030 |
Why?
|
| Time Factors | 4 | 2018 | 40075 | 0.030 |
Why?
|
| Heart Rate | 2 | 2017 | 4091 | 0.030 |
Why?
|
| Recurrence | 2 | 2017 | 8340 | 0.030 |
Why?
|
| Magnesium | 1 | 2018 | 813 | 0.030 |
Why?
|
| Body Temperature | 1 | 2018 | 777 | 0.030 |
Why?
|
| Electric Countershock | 1 | 2017 | 534 | 0.030 |
Why?
|
| Syncope | 1 | 2017 | 429 | 0.030 |
Why?
|
| Potassium | 1 | 2018 | 1336 | 0.030 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2017 | 493 | 0.030 |
Why?
|
| Logistic Models | 2 | 2019 | 13408 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 1179 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 2297 | 0.030 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2017 | 789 | 0.030 |
Why?
|
| Sodium | 1 | 2018 | 1623 | 0.030 |
Why?
|
| Creatinine | 1 | 2018 | 1919 | 0.030 |
Why?
|
| Pulmonary Veins | 1 | 2018 | 761 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 1133 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2018 | 9959 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2017 | 2110 | 0.020 |
Why?
|
| Europe | 1 | 2017 | 3339 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 1584 | 0.020 |
Why?
|
| Equipment Design | 1 | 2017 | 3582 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2017 | 1387 | 0.020 |
Why?
|
| Young Adult | 3 | 2019 | 56430 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2017 | 2268 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2018 | 2148 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5078 | 0.020 |
Why?
|
| Risk Factors | 3 | 2018 | 72290 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10397 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2017 | 3670 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 12245 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2017 | 5007 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2018 | 53288 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10388 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15076 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2017 | 4599 | 0.010 |
Why?
|
| Adult | 3 | 2019 | 214055 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2019 | 25625 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29063 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 57776 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 85781 | 0.010 |
Why?
|